Palonosetron Fresenius Kabi (Palonosetron Hydrochloride)

Palonosetron hydrochloride, the active ingredient in Palonosetron Fresenius Kabi, is a 5‑HT3 receptor antagonist presented as a sterile injectable solution for intravenous use. It is used to prevent nausea and vomiting associated with chemotherapy and postoperative settings in adult patients. GNH USA supplies Palonosetron Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

GNH USA supplies Palonosetron Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Palonosetron Fresenius Kabi is a 5‑HT3 receptor antagonist used in the management of nausea and vomiting related to chemotherapy and surgery.

- Chemotherapy‑induced nausea and vomiting (CINV): Provides long‑lasting prevention of acute and delayed CINV. - Post‑operative nausea and vomiting (PONV): Reduces the incidence of nausea and vomiting after surgical procedures. - Radiotherapy‑induced nausea and vomiting: Helps       ...